Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]MNI-968 biodistribution and safety in healthy subjects
NCT03142724Phase 1Completed
- Sponsor
- Molecular NeuroImaging
- Start
- May 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]MNI-968, sponsored by Molecular NeuroImaging. Primary endpoint: Whole body tomographic PET images for assessment of body organ distribution of radioactivity at 2 months. Started May 2017; status: completed.
02
Drugs
[18F]MNI-968
Beyond the preview
Go deeper on NCT03142724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142724.